In stock
CJC-1295 5mg + Ipamorelin 5mg Combo is a dual-peptide growth hormone–releasing research formulation studied for metabolic regulation, recovery signaling, sleep rhythm optimization, and performance enhancement. This synergistic blend is commonly explored in longevity and muscle research models seeking optimized GH and IGF-1 pathway activation.
In stock
Free Shipping for the orders over $250
Flexible and secure payment
Guaranteed Safe & Secure CheckoutThe CJC-1295 + Ipamorelin Combo combines two complementary peptides studied for their influence on endogenous growth hormone (GH) signaling. Each vial contains 5mg of CJC-1295 and 5mg of Ipamorelin, designed for research models evaluating GH pulsatility, metabolic efficiency, tissue recovery, and sleep-related hormonal rhythms.
CJC-1295 functions as a growth hormone–releasing hormone (GHRH) analog, while Ipamorelin acts as a selective growth hormone secretagogue (GHS). Together, they are frequently explored for amplifying natural GH and IGF-1 signaling without broadly affecting other endocrine pathways.
In research environments, protocols often evaluate 100–300 mcg of each peptide administered once or twice daily depending on study design. Common investigational cycles range from 8–12 weeks followed by rest intervals to maintain receptor sensitivity. Protocol structure varies based on metabolic, recovery, or longevity-focused research objectives.
Preclinical investigations indicate favorable tolerability within studied dosing ranges. Observations may include transient injection-site sensitivity, mild water retention, or temporary headache in certain models. Long-term human safety data remains under active investigation.
If your research focus involves growth hormone modulation, metabolic optimization, or recovery-based protocols, our team can assist in selecting the appropriate compounds and structuring a research-aligned strategy.
Important Notice: This compound is supplied strictly for laboratory research and analytical purposes only. Not for human consumption, medical use, or veterinary application.
| Package | Bottle (1 Vial), Box (10 Vials) |
|---|
SLUPP-332 is an advanced metabolic research peptide studied for its role in enhancing energy expenditure, improving metabolic efficiency, and supporting fat oxidation. It is commonly explored in research focused on endurance, mitochondrial function, and longevity-related metabolic optimization.
LL-37 is a human-derived antimicrobial peptide studied for its role in immune defense, tissue repair, and inflammatory regulation. It is widely researched for supporting innate immunity, enhancing wound healing processes, and maintaining skin and barrier integrity at a cellular level.
Bacteriostatic Water for Injection (BWFI) is a sterile, non-pyrogenic preparation of water containing 0.9% benzyl alcohol, added as a bacteriostatic preservative. This formulation is specifically designed to inhibit the growth of microorganisms, allowing for multiple withdrawals from a single vial under proper sterile conditions.
GHRP-6 is a synthetic growth hormone–releasing peptide studied for its ability to stimulate endogenous growth hormone (GH) secretion via ghrelin receptor activation. It is widely researched across muscle growth, metabolic health, recovery, and body-composition pathways.
